# Robert A. Anders

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-a-anders/

## Facts

| Field | Value |
| --- | --- |
| Citations | 77,395 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 100 |
| i10-index | 256 |
| Last Known Institution | Johns Hopkins University |
| OpenAlex ID | https://openalex.org/A5025711714 |
| ORCID iD | https://orcid.org/0000-0002-2363-9072 |
| Works | 724 |

## Researcher papers

Showing 12 of 13.

- [Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer](https://scholariq.org/papers/safety-activity-and-immune-correlates-of-anti-pd-1-antibody-in-cancer/)
- [PD-1 Blockade in Tumors with Mismatch-Repair Deficiency](https://scholariq.org/papers/pd-1-blockade-in-tumors-with-mismatch-repair-deficiency/)
- [Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade](https://scholariq.org/papers/mismatch-repair-deficiency-predicts-response-of-solid-tumors-to-pd-1-blockade/)
- [Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates](https://scholariq.org/papers/phase-i-study-of-single-agent-anti-programmed-death-1-mdx-1106-in-refractory/)
- [The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints](https://scholariq.org/papers/the-vigorous-immune-microenvironment-of-microsatellite-instable-colon-cancer-is/)
- [A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer](https://scholariq.org/papers/a-prospective-multi-institutional-pathologist-based-assessment-of-4/)
- [The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution](https://scholariq.org/papers/the-human-tumor-atlas-network-charting-tumor-transitions-across-space-and-time/)
- [Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)](https://scholariq.org/papers/pathologic-features-of-response-to-neoadjuvant-anti-pd-1-in-resected-non-small/)
- [LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems](https://scholariq.org/papers/lag-3-regulates-cd8-t-cell-accumulation-and-effector-function-in-murine-self-and/)
- [Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity](https://scholariq.org/papers/neoadjuvant-cabozantinib-and-nivolumab-convert-locally-advanced-hepatocellular/)
- [Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy](https://scholariq.org/papers/elective-nodal-irradiation-attenuates-the-combinatorial-efficacy-of-stereotactic/)
- [Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes](https://scholariq.org/papers/pathways-of-immune-exclusion-in-metastatic-osteosarcoma-are-associated-with/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Researcher university

- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.